Evidence map›Paper›PMID 42306630›Full record

ArticleMaterials today. Bio2026

Locally injectable visible light-cured carboxymethyl chitosan hydrogels with indocyanine green-methyl-β-cyclodextrin for breast cancer phototherapy.

Sun-Jung Yoon, Sae Hyun Kim, Wheemoon Cho, Gun-Jae Jung, Dong Nyoung Heo, Su-Hak Heo, Youngbum Yoo, Suk-Ho Moon, Heung Jae Chun, Dae Hyeok Yang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sun-Jung YoonResearch Institute of Clinical Medicine of Jeonbuk National University, Department of Orthopedic Surgery, Medical School, Jeonbuk National University, Jeonju, 54896, Republic of Korea.
Sae Hyun KimInstitute of Cell and Tissue Engineering, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
Wheemoon ChoInstitute of Cell and Tissue Engineering, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
Gun-Jae JungInstitute of Cell and Tissue Engineering, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
Dong Nyoung HeoDepartment of Dental Materials, School of Dentistry, Kyung Hee University, 26 Kyungheedae-Ro, Dongdaemun-Gu, Seoul, 02447, Republic of Korea.
Su-Hak HeoDepartment of Medicinal Bioscience, Konkuk University (Glocal Campus), Chungju-si, Chungcheongbuk-do, 27478, Republic of Korea.
Youngbum YooDepartment of Surgery, Konkuk University Medical Center, Seoul, 05030, Republic of Korea.
Suk-Ho MoonDepartment of Plastic & Reconstructive Surgery, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
Heung Jae ChunInstitute of Cell and Tissue Engineering, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
Dae Hyeok YangInstitute of Cell and Tissue Engineering, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemotherapy is the main therapy for triple-negative breast cancer (TNBC) but causes severe systemic toxicity. A hydrogel system that can be injected into the tumor along with photothermal/photodynamic combination therapy can potentially overcome systemic toxicity. Herein, we developed visible light-cured carboxymethyl chitosan methacrylate (CMCSMA) hydrogels containing an indocyanine green-methyl-β-cyclodextrin inclusion complex (ICG-ic-CD) as an injectable therapy for photo-triggered TNBC therapy.

Indexed as

Crosslinking densityIndocyanine green-methyl-β-cyclodextrin inclusion complexPhotodynamic therapyPhotothermal therapyTriple-negative breast cancerVisible light-cured carboxymethyl chitosan methacrylate

Identifiers

PMID42306630
PMCPMC13266137

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.